161 related articles for article (PubMed ID: 15324403)
21. Cutaneous and oral changes as the only manifestations of the glucagonoma syndrome.
Ditty JF; Lang PG
South Med J; 1982 Feb; 75(2):222-4. PubMed ID: 6277014
[No Abstract] [Full Text] [Related]
22. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
Wilkinson DS
Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
[TBL] [Abstract][Full Text] [Related]
23. [Benign pancreatic glucagonoma and recurrent pulmonary embolism with fatal course in a 36-year old man].
Sprogøe-Jakobsen U; Karkov JN
Ugeskr Laeger; 1991 Oct; 153(43):3015-6. PubMed ID: 1801389
[TBL] [Abstract][Full Text] [Related]
24. [Glucagonoma with diabetic ketoacidosis; case report].
Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
[TBL] [Abstract][Full Text] [Related]
25. Early detection of pancreatic glucagonoma.
Haga Y; Yanagi H; Urata J; Inada M; Shimada S; Nitahata N; Tanimura M
Am J Gastroenterol; 1995 Dec; 90(12):2216-23. PubMed ID: 8540521
[TBL] [Abstract][Full Text] [Related]
26. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
Pedersen NB; Jonsson L; Holst JJ
Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
[TBL] [Abstract][Full Text] [Related]
27. [Pseudoglucagonoma syndrome. Case report, therapeutic possibilities and hypotheses on the etiology].
Ossowski B; Baum C
Hautarzt; 1995 Mar; 46(3):173-6. PubMed ID: 7759243
[TBL] [Abstract][Full Text] [Related]
28. [Glucagonoma. A tumor disease with multiple clinical manifestations].
Andersson K; Wängberg B; Tisell LE; Nilsson O; Fjälling M; Forssell-Aronsson E; Ahrén B; Ahlman H
Lakartidningen; 1996 Aug; 93(35):2935-9. PubMed ID: 8815353
[TBL] [Abstract][Full Text] [Related]
29. [Pancreatic glucagonoma. Apropos of a case].
Mathis P; Diebold MD; Servel R
Chirurgie; 1987; 113(3):258-61. PubMed ID: 2820663
[No Abstract] [Full Text] [Related]
30. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
Vandersteen PR; Scheithauer BW
J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
[TBL] [Abstract][Full Text] [Related]
31. [The glucagonoma syndrome].
Rappersberger K; Wolff-Schreiner E; Konrad K; Wolff K
Hautarzt; 1987 Oct; 38(10):589-98. PubMed ID: 2824404
[TBL] [Abstract][Full Text] [Related]
32. Glucagonoma without cutaneous manifestations.
Parr JH; Ramsay ID; Keeling PW; Thompson RP; Mallinson CN
Postgrad Med J; 1985 Aug; 61(718):737-8. PubMed ID: 2994032
[TBL] [Abstract][Full Text] [Related]
33. Etiology and pathogenesis of necrolytic migratory erythema: review of the literature.
Tierney EP; Badger J
MedGenMed; 2004 Sep; 6(3):4. PubMed ID: 15520626
[TBL] [Abstract][Full Text] [Related]
34. [The glucagonoma syndrome. Review of the literature. Apropos of a case].
Penchet A; Olivier A; Passa P; Orsoni JL; Charleux H
J Chir (Paris); 1986 Mar; 123(3):157-63. PubMed ID: 2873145
[TBL] [Abstract][Full Text] [Related]
35. The glucagonoma syndrome--report of a case without overt diabetes.
Leibovici V; Granot E; Eid A; Goldin E; Okon E
J Dermatol; 1987 Oct; 14(5):491-6. PubMed ID: 2830323
[No Abstract] [Full Text] [Related]
36. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
Elsborg L; Glenthøj A
Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
[TBL] [Abstract][Full Text] [Related]
37. Treatment of necrolytic migratory erythema in glucagonoma syndrome.
Shepherd ME; Raimer SS; Tyring SK; Smith EB
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):925-8. PubMed ID: 1761771
[TBL] [Abstract][Full Text] [Related]
38. The glucagonoma syndrome. Clinical and pathologic features in 21 patients.
Wermers RA; Fatourechi V; Wynne AG; Kvols LK; Lloyd RV
Medicine (Baltimore); 1996 Mar; 75(2):53-63. PubMed ID: 8606627
[TBL] [Abstract][Full Text] [Related]
39. Retrobulbar neuritis as the first sign of the glucagonoma syndrome.
Lambrecht ER; van der Loos TL; van der Eerden AH
Int Ophthalmol; 1987 Oct; 11(1):13-5. PubMed ID: 2826358
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.
van der Loos TL; Lambrecht ER; Lambers JC
J Am Acad Dermatol; 1987 Feb; 16(2 Pt 2):468-72. PubMed ID: 3029193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
